8461 - 8470 of 8571 Results
Title
Year
- Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism2023RESTRICTEDTitle: Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 4Start Page: 714End Page: 715Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29353Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10501730Citation Count: 3
-
OPENTitle: Why Therapeutic Trials Fail in Primary TauopathiesJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 4Start Page: 545End Page: 550Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29322Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10398638Citation Count: 4
-
OPENTitle: Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 885End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29358Citation Count: 31
- Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay2024OPENTitle: Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assayJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 4Start Page: 2444End Page: 2452Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.13658Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13658Citation Count: 55
-
OPENTitle: Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral SclerosisJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 5Start Page: 807End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26462Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9588516Citation Count: 28
- Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage2024OPENTitle: Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stageJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 4Start Page: 2680End Page: 2697Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/alz.13729Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13729Citation Count: 5
- LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification2023OPENTitle: LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversificationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 44Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adh9543Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adh9543Citation Count: 29
- Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation2023OPENTitle: Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 46Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adi8716Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adi8716Citation Count: 78
- Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures2023OPENTitle: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structuresJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 48Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adk6191Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adk6191Citation Count: 27
-
OPENTitle: Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2Journal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 382Issue #: 6677Start Page: 1404End Page: 1411Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/science.adi9926Best OA location URL: https://www.science.org/doi/pdf/10.1126/science.adi9926Citation Count: 42